A plaintiff, Judith B., files a products liability litigation against the manufacturers of Taxotere, after developing permanent hair loss after taking the medication.

According to her Taxotere lawsuit, Judith suffered permanent alopecia after Taxotere was used as part of her chemotherapy regimen.

Judith is a resident of the state of Texas and files the lawsuit in Louisiana federal court, where the Taxotere multidistrict litigation is being conducted. She alleges that she first started using the medication in June 2012, continuing treatment through September 2012.

The nature of her injuries, as alleged in the Taxotere permanent alopecia lawsuit, is that she developed disfiguring permanent alopecia beginning sometime after treatment with Taxotere, also known as docetaxel. This development has continued to the present.

The alleged counts being faced by the defendant include: 1) Strict Products Liability, 2) Negligence, 3) Negligent Misrepresentation, 4) Fraudulent Misrepresentation, 5) Fraudulent Concealment, 6) Fraud and Deceit.

The Permanent Alopecia After Taxotere Lawsuit Joins MDL

Judith’s claim is filed as part of a large multidistrict litigation, or MDL, centered on allegations that the drug Taxotoere causes permanent alopecia when women use the prescribed medication for treatment throughout their chemotherapy when battling breast cancer.

Hair loss, also known as alopecia, is a common symptom or side effect of those whom undergo chemotherapy treatment. It is likely the most common side effect seen that most cancer patients deal with and undergo.

Most of these patients, however, know of the risks involved when undergoing chemotherapy treatment and that hair loss, or alopecia, is a likely side effect to the treatment. But most of these patients are under the belief that once chemotherapy treatment is done, their hair will eventually grow back.

More so, as alleged throughout the permanent alopecia after Taxotere lawsuits, an increasing number of patients have been left with permanent hair loss, unable to grow their hair back at all. Other former patients of Taxotere have allegedly been able to grow some of their hair back, but only in patches and clumps.

Taxotere Facts

According to the Taxotere lawsuit, the drug manufacturer Sanofi S.A. has been facing allegations that it should have known or did know that the drug would cause and be linked to such hair loss complications as permanent alopecia.

Plaintiffs, much like Judith, allege that the defendant not only failed in adequately and sufficiently warning about the alleged risks involved in using Taxotere throughout chemotherapy treatment, but also allegedly actively concealed information about side effects while they promoted the efficacy and safety of the drug. Plaintiffs contend that the manufacturer was aware of clinical studies stating the link between Taxotere and permanent hair loss as far back as 1996.

The Permanent Alopecia After Taxotere Lawsuit is Case No 2:17-cv-09398-KDE-MBN, in the U.S. District Court, Eastern District of Louisiana. The Taxotere Lawsuit MDL is In re: Taxotere (Docetaxel) Products Liability Litigation, MDL No 2740, in the U.S. District Court for the Eastern District of Louisiana.